🇺🇸 FDA
Patent

US 7335477

Truncated recombinant major outer membrane protein antigen (r56) of Orientia tsutsugamushi strains Karp, Kato and Gilliam and its use in antibody based detection assays and vaccines

granted A61KA61K2039/53A61K39/00

Quick answer

US patent 7335477 (Truncated recombinant major outer membrane protein antigen (r56) of Orientia tsutsugamushi strains Karp, Kato and Gilliam and its use in antibody based detection assays and vaccines) held by United States of America as represented by the Secretary of the Air Force expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2039/53, A61K39/00